Question 1141
Topic: Biology, Genetics & Bone HealingCorrect Answer & Explanation
. TCIRG1 (V-type proton ATPase subunit)
Practice Set 58 of 212
This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.
. TCIRG1 (V-type proton ATPase subunit)
Nitrogen-containing bisphosphonates (e.g., alendronate, zoledronic acid) inhibit osteoclast function primarily by targeting which of the following enzymes in the mevalonate pathway?
. Farnesyl pyrophosphate synthase
Sclerostin is a glycoprotein secreted by osteocytes that serves as a potent negative regulator of bone formation. It achieves this primarily by binding to which of the following cellular targets?
. LRP5/6 receptors
Endochondral ossification is the primary mechanism of bone formation in fracture callus. Which of the following transcription factors is recognized as the master regulator of chondrocyte differentiation in this process?
. Sox9
Continuous, chronic elevation of parathyroid hormone (PTH) leads to net bone resorption. This resorptive effect is primarily mediated by PTH initially binding to receptors on which cell type?
. Osteoblasts
The primary mechanism of action of denosumab in treating osteoporosis is through binding to and inhibiting which of the following molecules?
. RANKL
During distraction osteogenesis (e.g., Ilizarov technique), new bone is formed primarily through which of the following processes?
. Intramembranous ossification
A patient with severe malnutrition presents with bleeding gums, petechiae, and poor wound healing. A deficiency in which of the following vitamins is responsible for these symptoms by impairing the hydroxylation of proline and lysine in collagen synthesis?
. Vitamin C
Sclerostin is a protein that regulates bone mass. It functions primarily by antagonizing which of the following cellular signaling pathways?
. Wnt/beta-catenin pathway
Bone morphogenetic proteins (BMPs) initiate intracellular signaling through transmembrane serine/threonine kinase receptors. Which of the following downstream intracellular mediators are primarily activated by BMPs?
. Smad 1, 5, and 8
Which of the following cells produces osteoprotegerin (OPG), acting as a decoy receptor to prevent bone resorption?
. Osteoblasts
A 65-year-old woman is prescribed teriparatide for severe osteoporosis. What is the primary mechanism of action of this medication?
. Stimulation of intermittent parathyroid hormone receptors to increase osteoblast activity
. Type II
A patient presents with hypocalcemia following a total thyroidectomy. How does the body naturally attempt to correct this via parathyroid hormone (PTH) release?
. Increasing renal excretion of phosphate
Denosumab is a targeted biological therapy used to treat severe osteoporosis. What is its specific molecular target?
. RANKL
Compared to mature lamellar bone, woven bone is characterized by which of the following properties?
. Greater number of osteocytes per unit volume
Sclerostin, a glycoprotein produced primarily by osteocytes, regulates bone formation by directly inhibiting which of the following intracellular signaling pathways?
. Wnt/beta-catenin
During normal bone remodeling, RANKL binds to RANK on the surface of osteoclast precursors to stimulate differentiation. Which of the following molecules acts as a decoy receptor to inhibit this specific interaction?
. Osteoprotegerin (OPG)
Intermittent low-dose administration of teriparatide promotes an overall anabolic effect on bone. What is the primary cellular mechanism responsible for this bone formation?
. Stimulation of osteoblast survival and proliferation
Sclerostin is a glycoprotein secreted by osteocytes that serves as a key negative regulator of bone mass. It achieves this primarily by binding to LRP5/6 receptors and inhibiting which intracellular signaling pathway?
. Wnt/beta-catenin